Cite
HARVARD Citation
Smolen, J. et al. (n.d.). FRI0150 Maintenance of remission in rheumatoid arthritis patients with low-moderate disease activity following withdrawal of certolizumab PEGOL treatment: Week 52 results from the certain study. Annals of the rheumatic diseases. pp. 361-362. [Online].